Fund Holdings — ACUTA CAPITAL PARTNERS, LLC

Total Portfolio Value:
$153.94M
Total Bought:
$40.25M
Total Sold:
$90.45M
Net Transaction:
-$50.19M
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Ocular Therapeutix, Inc.(OCUL)1,310,0002,635,287+1,325,287$5.84M$23.98M15.58%+$18.14M
Praxis Precision Medicines, Inc.(PRAX)299,636162,302-137,334$6.68M$9.90M6.43%+$3.23M
Mersana Therapeutics Inc2,368,0002,164,628-203,372$5.49M$9.70M6.30%+$4.20M
Taysha Gene Therapies, Inc.(TSHA)3,589,3333,333,333-256,000$6.35M$9.57M6.21%+$3.21M
Rocket Pharmaceuticals, Inc.(RCKT)366,015326,787-39,228$10.97M$8.80M5.72%-$2.17M
Sarepta Therapeutics, Inc.(SRPT)70,60064,162-6,438$6.81M$8.31M5.40%+$1.50M
Vaxcyte, Inc.(PCVX)117,373104,830-12,543$7.37M$7.16M4.65%-$210.1K
Enliven Therapeutics Inc123,876396,099+272,223$1.71M$6.97M4.53%+$5.25M
Tourmaline Bio Inc231,882261,108+29,226$6.07M$5.98M3.88%-$91.3K
Applied Therapeutics Inc525,100792,000+266,900$1.76M$5.39M3.50%+$3.63M
Dyne Therapeutics, Inc.(DYN)147,836184,500+36,664$1.97M$5.24M3.40%+$3.27M
Disc Medicine, Inc.(IRON)115,50076,800-38,700$6.67M$4.78M3.11%-$1.89M
Revolution Medicines, Inc.(RVMD)160,000143,777-16,223$4.59M$4.63M3.01%+$45.1K
Celldex Therapeutics, Inc.(CLDX)69,400109,000+39,600$2.75M$4.57M2.97%+$1.82M
Whitehawk Therapeutics, Inc.(WHWK)1,849,4021,849,4020$3.74M$4.33M2.81%+$591.8K
Hillevax Inc324,600250,609-73,991$5.21M$4.17M2.71%-$1.04M
Crinetics Pharmaceuticals87,50078,403-9,097$3.11M$3.67M2.38%+$556.8K
Viridian Therapeutics, Inc.(VRDN)281,500199,433-82,067$6.13M$3.49M2.27%-$2.64M
Terns Pharmaceuticals Inc555,260465,079-90,181$3.60M$3.05M1.98%-$552.7K
Immunovant, Inc.(IMVT)119,48992,346-27,143$5.03M$2.98M1.94%-$2.05M
Verastem, Inc.(VSTM)232,249207,095-25,154$1.89M$2.44M1.59%+$553.2K
Arcellx Inc
COMMON STOCK
77,00034,500-42,500$4.27M$2.40M1.56%-$1.87M
Kura Oncology, Inc.(KURA)701,34990,000-611,349$10.09M$1.92M1.25%-$8.17M
Insmed Incorporated(INSM)29,50061,718+32,218$914.2K$1.67M1.09%+$760.2K
Agios Pharmaceuticals, Inc.(AGIO)055,262+55,262$0$1.62M1.05%+$1.62M
ORIC Pharmaceuticals, Inc.(ORIC)0103,992+103,992$0$1.43M0.93%+$1.43M
Mereo BioPharma Group plcADS(MREO)0397,884+397,884$0$1.31M0.85%+$1.31M
Lyra Therapeutics Inc0173,320+173,320$0$1.08M0.70%+$1.08M
Cypherpunk Technologies Inc.(CYPH)354,166354,1660$1.47M$942.1K0.61%-$525.9K
Ultragenyx Pharmaceutical Inc.(RARE)020,000+20,000$0$933.8K0.61%+$933.8K
Intra-Cellular Therapies Inc.013,300+13,300$0$920.4K0.60%+$920.4K
Cellectar Biosciences, Inc.(CLRB)477,500143,500-334,000$1.32M$571.1K0.37%-$751.5K
Nuvation Bio Inc.W EXP 07 07 2027(NUVB)90,83290,8320$5.5K$27.5K0.02%+$22.0K
An2 Therapeutics Inc132,0000-132,000$2.70M$0—-$2.70M
Apellis Pharmaceuticals Inc
COM
76,1000-76,100$4.56M$0—-$4.56M
argenx SEADR(ARGX)2,4000-2,400$913.0K$0—-$913.0K
Centessa Pharmaceuticals PlcADS38,1380-38,138$303.6K$0—-$303.6K
Cymabay Therapeutics Inc492,1550-492,155$11.62M$0—-$11.62M
EyePoint, Inc.(EYPT)425,1280-425,128$9.82M$0—-$9.82M
4d Molecular Therapeutics Inc74,5000-74,500$1.51M$0—-$1.51M
Rayzebio Inc378,0690-378,069$23.50M$0—-$23.50M
Springworks Therapeutics Inc10,0000-10,000$365.0K$0—-$365.0K
Tyra Biosciences, Inc.(TYRA)8,8670-8,867$122.8K$0—-$122.8K
Verona Pharma PlcADS19,0000-19,000$377.7K$0—-$377.7K
Page 1 of 1
ACUTA CAPITAL PARTNERS, LLC — 13F Holdings — Q1 2024 | TickerTrail